Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Müller

Showing results (241-250 of 308) with videos related to

Pageof 31
Sort By:
Mental Illness|December 6, 2014
Infectious Agents are Associated with Psychiatric DiseasesDaniela Lydia Krause, Elif Weidinger, Judith Matz, et al.
Journal of Neurology|February 25, 2010
Cost of illness in patients with Gilles de la Tourette's syndromeInes Dodel, Jens Peter Reese, Norbert Müller, et al.
Molecular and Cellular Probes|June 1, 2016
A dual PCR-based sequencing approach for the identification and discrimination of Echinococcus and Taenia taxaGhalia Boubaker, Irina Marinova, Francesca Gori, et al.
Frontiers in Psychiatry|March 1, 2017
High Kynurenine (a Tryptophan Metabolite) Predicts Remission in Patients with Major Depression to Add-on Treatment with CelecoxibDaniela Krause, Aye-Mu Myint, Christine Schuett, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 25, 2012
Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6Daniela L Krause, Jenny K Wagner, Agnes Wildenauer, et al.
ACS Applied Bio Materials|January 14, 2022
Insight into Antimicrobial Properties via Self-Acidification of Compounds from the Molybdenum-Tungsten-Oxygen SystemZuzana Gajarska, Karl Christian Zelenka, Petr Rathner, et al.
Journal of Psychiatric Research|April 27, 2017
Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trialsWei Zheng, Dong-Bin Cai, Xin-Hu Yang, et al.
Schizophrenia Research|June 24, 2010
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatmentNorbert Müller, Daniela Krause, Sandra Dehning, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 4, 2005
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptomsMichael Riedel, Norbert Müller, Martin Strassnig, et al.
Journal of Psychiatric Research|June 2, 2015
Obsessive-compulsive disorder--A question of conscience? An fMRI study of behavioural and neurofunctional correlates of shame and guiltKristina Hennig-Fast, Petra Michl, Johann Müller, et al.
Pageof 31

Showing results (241-250 of 308) with videos related to

Sort By:
Pageof 31
Mental Illness|December 6, 2014
Infectious Agents are Associated with Psychiatric DiseasesDaniela Lydia Krause, Elif Weidinger, Judith Matz, et al.
Journal of Neurology|February 25, 2010
Cost of illness in patients with Gilles de la Tourette's syndromeInes Dodel, Jens Peter Reese, Norbert Müller, et al.
Molecular and Cellular Probes|June 1, 2016
A dual PCR-based sequencing approach for the identification and discrimination of Echinococcus and Taenia taxaGhalia Boubaker, Irina Marinova, Francesca Gori, et al.
Frontiers in Psychiatry|March 1, 2017
High Kynurenine (a Tryptophan Metabolite) Predicts Remission in Patients with Major Depression to Add-on Treatment with CelecoxibDaniela Krause, Aye-Mu Myint, Christine Schuett, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 25, 2012
Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6Daniela L Krause, Jenny K Wagner, Agnes Wildenauer, et al.
ACS Applied Bio Materials|January 14, 2022
Insight into Antimicrobial Properties via Self-Acidification of Compounds from the Molybdenum-Tungsten-Oxygen SystemZuzana Gajarska, Karl Christian Zelenka, Petr Rathner, et al.
Journal of Psychiatric Research|April 27, 2017
Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trialsWei Zheng, Dong-Bin Cai, Xin-Hu Yang, et al.
Schizophrenia Research|June 24, 2010
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatmentNorbert Müller, Daniela Krause, Sandra Dehning, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 4, 2005
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptomsMichael Riedel, Norbert Müller, Martin Strassnig, et al.
Journal of Psychiatric Research|June 2, 2015
Obsessive-compulsive disorder--A question of conscience? An fMRI study of behavioural and neurofunctional correlates of shame and guiltKristina Hennig-Fast, Petra Michl, Johann Müller, et al.
Pageof 31